SCHEMBL5116783

SCHEMBL5116783

Cc1noc(-c2ccc(-c3cc(NC(=O)c4ccoc4)ccc3C)cc2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 15/20 0.58
HSPB1 P04792 1/20 0.58
RAB9A P51151 2/20 0.46
KCNK3 O14649 1/20 0.43
KCNK9 Q9NPC2 1/20 0.43
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
BRAF P15056 2/20 0.40
MAPK13 O15264 1/20 0.40
KDR P35968 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5124496 0.82 MAPK14 (0.57) MAPK14HSPB1RAB9AKCNK3KCNK9
SCHEMBL5122976 0.82 MAPK14 (0.62) MAPK14HSPB1KDRMAPK11
SCHEMBL4701504 0.81 MAPK14 (0.69) MAPK14HSPB1RAB9AKCNK3KCNK9
SCHEMBL4702778 0.79 MAPK14 (0.66) MAPK14HSPB1RAB9AKCNK3KCNK9
SCHEMBL3522459 0.79 MAPK14 (0.56) MAPK14HSPB1RAB9AKCNK3KCNK9
SCHEMBL4819651 0.79 MAPK14 (0.74) MAPK14HSPB1
SCHEMBL5123381 0.78 MAPK14 (0.56) MAPK14HSPB1RAB9AMEN1ALDH1A1
SCHEMBL4822705 0.77 MAPK14 (0.72) MAPK14HSPB1
SCHEMBL4811975 0.76 MAPK14 (0.71) MAPK14HSPB1
SCHEMBL4816542 0.76 MAPK14 (0.62) MAPK14HSPB1RAB9AKCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425555-B2 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-09-16 US disclosed
US-7425555-B2 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-09-16 US disclosed
US-7425555-B2 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-09-16 US disclosed
US-20060089393-A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors GLAXOSMITHKLINE LLC 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089393-A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors MAPK1, MAPK7, MAP3K1 MAPK14 8/4885HSPB1 158/4885RAB9A 1260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.